Loading
Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹0.75Admitted-Finance | ₹0.75 | L1 | Admitted-Finance |
| 2 | L2₹0.89Admitted-Finance | ₹0.89 | L2 | Admitted-Finance |
| 3 | L3₹0.91Admitted-Finance | ₹0.91 | L3 | Admitted-Finance |
| 4 | L4₹1.34Admitted-Finance | ₹1.34 | L4 | Admitted-Finance |
| 5 | L5₹3,672.90Admitted-Finance SHOP NO 7 C2C MARKET NO 1 POCKET 2 JANAKPURI DELHI | NEW DELHI | DELHI | 110001 | ₹3,672.90 | L5 | Admitted-Finance |
| Sl No | Description | Qty | Unit | NEW LIFE MEDICOS L6 | Gagan Associates L10 | UJJAWAL OVERSEAS (I) PVT LTD L3 | GOYAL PHARMACEUTICALS L5 | SMPL Life Sciences Pvt. Ltd. L8 | Sajiva Medsales Private Limited L2 | SHIVAAY PHARMACY L1 | DPNR Medicals L4 | Mahaluxmi Surgical AND Medicine Distributors L9 | MASTODON BIOTECH L7 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.00Dept of Endo | |||||||||||||
| 1.01 | DENOSUMAB 60MG INJ | 86 | No | 4,028 ₹4,229.4 | - | - | 3,498 ₹3,672.9 | 3,365 ₹3,533.25 | - | - | - | - | - |
| 2.01 | Octreotide LAR 20mg Inj | 41 | VIAL | - | - | - | - | 7,920 ₹8,316 | - | - | - | 12,300 ₹12,915 | 9,600 ₹10,080 |
| 3.01 | Inj Romosozumab 210mg/2.34ml (pack of 2 PFS) | 23 | PFS | - | 22,405 ₹23,525.25 | - | - | - | - | - | - | - | - |
| 4.01 | Dapagliflozin 5 Mg Tab | 18,000 | No | - | - | 0.87 ₹0.91 | - | 0.7 ₹0.73 | 0.85 ₹0.89 | 0.71 ₹0.75 | 0.44 ₹0.46 | - | - |
| 5.01 | Glipizide 5mg Tab | 2,600 | No | - | - | - | - | - | - | - | 0.84 ₹0.88 | - | - |
Tender Value
₹12.0 L
EMD Value
₹59,922
Closing Date
20 May 2026, 6:00 pmClosed
THE COMMANDANT ARMY HOSPITAL R AND R
THE COMMANDANT ARMY HOSPITAL R AND R DELHI CANTT
2433/MS/EXP/D 824, 646/Endo(Drugs)/IFA RE-22/2026-27 FOR AHRR
2026_ARMY_762797_1
2433/MS/EXP/D 824, 646/Endo(Drugs)/IFA RE-22/2026-27
Open Tender
Medical Equipments/Waste
ARMY HOSPITAL R AND R DELHI CANTT
Please refer Tender documents.
2 documents required · 2 mandatory
₹0
₹59,922
Yes
4 Jul 2026
30 Apr 2026
21 May 2026
30 Apr 2026
20 May 2026
30 Apr 2026
30 Apr 2026 - 20 May 2026
| Sl No | Description | Qty | Unit | Est. Rate | Est. Amount |
|---|---|---|---|---|---|
| 1Dept of Endo | |||||
| 1.01 | DENOSUMAB 60MG INJ | 86 | No | - | - |
| 2.01 | Octreotide LAR 20mg Inj | 41 | VIAL | - | - |
| 3.01 | Inj Romosozumab 210mg/2.34ml (pack of 2 PFS) | 23 | PFS | - | - |
| 4.01 | Dapagliflozin 5 Mg Tab | 18,000 | No | - | - |
| 5.01 | Glipizide 5mg Tab | 2,600 | No | - | - |
stage.html
html • 0.05 MB
tech_bid_open.pdf
tech_eval.pdf
fin_bid_open.pdf
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Tendernotice_1.pdf
PDF • 0.57 MB
RFP.pdf
Tender Documents • 1.31 MB
BOQ_854455.xls
BOQ • 0.86 MB
Download all tender documents and submit your bid